alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT
      32**







**CERTIFICATION
      OF CHIEF EXECUTIVE OFFICER**


**AND
      CHIEF FINANCIAL OFFICER**


**PURSUANT
      TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**





Carol
      K.
      Nelson, Chief Executive Officer and President, and Lars H. Johnson, Chief
      Financial Officer of Cascade Financial Corporation (the "Corporation"), each
      certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
      906 of the Sarbanes-Oxley Act of 2002:





1.
            The
                Form 10-Q of the Corporation for the quarterly period ended June
                30, 2007
                (the "Form 10-Q"), fully complies with requirements of Section 13(a)
                or
                15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d));
                and





2.
            The
                information contained in the Form 10-Q fairly presents, in all material
                respects, the financial condition, and results of operations of the
                Corporation.





This
      certification is being furnished solely for purposes of Section 906 and is
      not
      being filed as part of this quarterly report.








Date:
      August 7, 2007








/s/
      Carol K.
      Nelson


Carol
      K.
      Nelson, President and CEO








/s/
      Lars H.
      Johnson


Lars
      H.
      Johnson, Chief Financial Officer
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 98-7828

JEAN-CLAUDE RINEHART,

Plaintiff - Appellant,

versus

JOEL H. BREWER, Person County District Attorney; PERSON COUNTY SHERIFF’S DEPARTMENT;

GAIL SHULL, Detective, Person County Sheriff’s

Department,

Defendants - Appellees.

Appeal from the United States District Court for the Middle District of North Carolina, at Durham. N. Carlton Tilley, Jr., District Judge. (CA-97-713-1)

Submitted: February 25, 1999 Decided: March 10, 1999

Before HAMILTON, WILLIAMS, and MICHAEL, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Jean-Claude Rinehart, Appellant Pro Se. Mark John Pletzke, OFFICE

OF THE ATTORNEY GENERAL OF NORTH CAROLINA, Raleigh, North Carolina;

Keith David Burns, FAISON & GILLESPIE, Durham, North Carolina, for

Appellees.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Jean-Claude Rinehart appeals the district court’s order denying relief on his 42 U.S.C.A. § 1983 (West Supp. 1998) complaint.

We have reviewed the record and the district court’s opinion

accepting the magistrate judge’s recommendation and find no reversible error. Accordingly, we affirm on the reasoning of the

district court. See Rinehart v. Brewer, No. CA-97-713-1 (M.D.N.C.

Nov. 6, 1998). We dispense with oral argument because the facts

and legal contentions are adequately presented in the materials

before the court and argument would not aid the decisional process.

AFFIRMED
Exhibit 10.5
                                                     ------------
                                                                 
                         Loan Agreement

                             between

       Mettler-Toledo AG, Im Langacher, CH-8606 Greifensee

                (hereinafter referred to as "MT")

and

       Robert F. Spoerry, Wengirain 42, CH-8702 Herrliberg

           (hereinafter referred to as "R.  Spoerry")



ART. I

1.1  MT grants a loan to R. Spoerry in the amount of CHF
     1,000,000 (one million Swiss Francs) for the purchase of
     equity of MT Investors Inc. (the "Loan").
     
1.2  The Loan will be made available by MT to R. Spoerry
     immediately upon his written request.
     
ART. 2

2.1  MT shall be entitled to request the repayment of the Loan at
     any time after the expiration of 7 calendar years after the
     date of this agreement ("Lifetime").  Such request shall be
     made in writing not less than 90 days before the date of
     repayment.
     
2.2  R. Spoerry shall have the right to fully or partly repay the
     Loan at any time.
     
ART. 3

3.1  The Loan shall be interest bearing at a rate of 5% p.a.
     ("Interest Rate").
     
3.2  Interest shall be payable semi-annually (per June 30 and
     December 31 of each calendar year) on the pro rata amount of
     the outstanding Loan.
     
3.3  The first interest period shall be not earlier than the date
     of the "Closing" as defined in the purchase agreement
     between AEA and Ciba-Geigy and shall end at December 31,
     1996.
     
ART. 4

4.1  This Loan Agreement shall be an appendix to and an integral
     part of the Employment Agreement between R. Spoerry and MT.
     
ART. 5

5.1  This Loan Agreement shall be governed and interpreted
     exclusively by and according to Swiss law.
     
5.2  Place of jurisdiction for any dispute arising from this Loan
     Agreement shall be Greifensee, Zurich.
     

Greifensee, October 7, 1996


Robert F. Spoerry   Mettler-Toledo AG


/s/ Robert F. Spoerry    /s/ Fred Ort   /s/ Peter Burker
---------------------    ------------   ----------------
EXHIBIT 31.2



CERTIFICATION



I, Riaz Latifullah, certify that:



|1. | I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Grandparents.com, Inc.; and
|-- | -----------------------------------------------------------------------------------------------------



|2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|Date: September 9, 2014 | /s/ Riaz Latifullah    
|----------------------- | -----------------------
|                        | Riaz Latifullah        
|                        | Chief Financial Officer
### IN THE SUPREME COURT OF THE STATE OF MONTANA DA 23 -0719

_________________ IN THE MATTER OF THE ESTATE OF: WARREN DAN EDDLEMAN,

Deceased. O R D E R

_________________ Pursuant to M. R. App. P. 16(5), the parties to this appeal have stipulated to the dismissal of the appeal by Appellant Morro Bay Ranch Limited Partnership. IT IS THEREFORE ORDERED that this appeal is DISMISSED as to Appellant Morro Bay Ranch Limited Partnership. This appeal may proceed as to the other parties. The Clerk is directed to provide a copy of this Order to all parties of record.

Electronically signed by: Mike McGrath Chief Justice, Montana Supreme Court

April 30 2024

04/30/2024
Case Number: DA 23-0719
STATE v. Elizabeth Paige McMAHAN.

No. 657P05.

Supreme Court of North Carolina.

November 29, 2005.

Matthew D. Wunsche, Assistant Appellate Defender, for McMahan.

Roxann Vaneekhoven, District Attorney, for State.

The following order has been entered on the motion filed on the 29th day of November 2005 by Attorney General for Temporary Stay:

"Motion Allowed by order of the Court in conference this the 29th day of November 2005."
##### 



EXHIBIT 32.2


CERTIFICATION OF CHIEF FINANCIAL
OFFICER

Pursuant to 18 U.S.C. § 1350, as
created by Section 906 of the Sarbanes-Oxley Act of 2002,
the undersigned officer of Dex Media West LLC (the
Company) hereby certifies, to such
officers knowledge, that:



| |                                                                                                                                                                                                                                                                                                  
| | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | (i) the accompanying Quarterly Report on
    Form 10-Q of the Company for the quarterly period ended
    March 31, 2004 (the Report) fully
    complies with the requirements of Section 13(a) or
    Section 15(d), as applicable, of the Securities Exchange
    Act of 1934, as amended; and
|
| | (ii) the information contained in the Report
    fairly presents, in all material respects, the financial
    condition and results of operations of the Company.                                                                                                                                



| |                              
| | -----------------------------
| | /s/ ROBERT M. NEUMEISTER, JR.
| |                              
| | Robert M. Neumeister, Jr.    
| | Executive Vice President and 
| | Chief Financial Officer      

Dated: May 21, 2004
Exhibit
32.2





TELETOUCH
COMMUNICATIONS, INC.





OFFICER’S
CERTIFICATION


PURSUANT
TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002


(18
U.S.C. 1350)





In
connection with the Quarterly Report on Form 10-Q of TELETOUCH COMMUNICATIONS,
INC. (the “Company”) for the quarter ended November 30, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), the
undersigned, Douglas E. Sloan, Chief Financial Officer of the Company, hereby
certifies, pursuant to 18 U.S.C. Section 1350, that, to the best of his
knowledge:





1.
            The
      Report is in full compliances with the requirements of Section 13(a) or
      15(d) of the Securities Exchange Act of 1934;
  and





2.           
The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operation of the
Company.





/s/ Douglas E.
      SloanDouglas
      E. SloanChief
      Financial OfficerJanuary
      14, 2011
BOLES v. URGENT CARE PHARMACY, INC.

No. COA05-540.

North Carolina Court of Appeals.

Filed July 18, 2006.

Certification Date August 7, 2006.

Appeal from Moore (03CVS1332, 03CVS1341).

Case without published opinion. Appeals dismissed.
EXHIBIT 32.1


CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the quarterly report of Apollo Investment Corporation (the “Company”) on Form 10-Q for the period ended September 30, 2019 (the “Report”), I, Howard Widra, Chief Executive Officer of the Company, and I, Gregory W. Hunt, Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


|   |                                                                                                                                       
|-- | --------------------------------------------------------------------------------------------------------------------------------------
|1. | To my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

|   |                                                                                                                                                     
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------
|2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ HOWARD WIDRAHoward WidraChief Executive OfficerNovember 5, 2019


/s/ GREGORY W. HUNTGregory W. HuntChief Financial Officer and TreasurerNovember 5, 2019
EX-10.1






[RAIT Letterhead]




	 	 	 	 	 
	July __, 2005
	[Name of Non-Employee Trustee]
	[Address]
	Re:	 	Redemption of Phantom Shares Under the Phantom Share Plan






Dear      :



Earlier this year, the shareholders of RAIT Investment Trust (“RAIT”) approved an amendment to
the RAIT Investment Trust 2005 Equity Compensation Plan (formerly known as the RAIT Investment
Trust 1997 Stock Option Plan) (the “Equity Plan”) which, among other changes, provided that phantom
shares awarded under the RAIT Investment Trust Phantom Share Plan (the “Phantom Plan”) may be
redeemed as common shares of beneficial interest, par value $0.01, of RAIT (the “Shares”) that will
be issued under the Equity Plan.



As a result of this amendment to the Equity Plan, the Compensation Committee of the Board of
Trustees of RAIT (the “Committee”) has determined that all phantom shares awarded under the Phantom
Plan will be redeemed as Shares, instead of the cash equivalent value of such Shares on the
designated redemption date. The Phantom Plan and your grant agreements specifically provide the
Committee with the discretion to determine after the date of grant of your phantom shares that such
phantom shares may be redeemed as Shares. Therefore, upon your separation from service from RAIT,
each phantom share credited to your account under the Phantom Plan will be redeemed for one Share
that will be issued to you under the Equity Plan. No cash will be paid to you for the redemption
of your phantom shares. This change in the form of redemption of phantom shares applies to all
phantom shares that you have been awarded under the Phantom Plan. Except as described above, your
grant agreements awarding you phantom shares are unchanged.



Please sign and date this letter where indicated below to acknowledge your receipt of this
letter and your understanding to the change in the form of the redemption of your phantom shares
under the Phantom Plan. You should keep a copy of this letter with your phantom share grant
agreements.



If you have any questions regarding this change in the form of redemption of your phantom
shares, please contact      at      .



Sincerely,



     



I hereby understand and agree that all of the phantom shares issued to me under the Phantom
Plan will be redeemed for an equivalent number of Shares issued under the Equity Plan, instead of
the cash value of such Shares, on the applicable redemption date.



Date:     Trustee:
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5574 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 5574

   To prohibit the transport of hydrolysate from the Pueblo Chemical 
Depot, Colorado, or the Blue Grass Army Depot, Kentucky, to an off-site 
                               location.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 10, 2008

  Mr. Salazar (for himself, Mr. Udall of Colorado, and Mr. Chandler) 
 introduced the following bill; which was referred to the Committee on 
                             Armed Services

_______________________________________________________________________

                                 A BILL

 
   To prohibit the transport of hydrolysate from the Pueblo Chemical 
Depot, Colorado, or the Blue Grass Army Depot, Kentucky, to an off-site 
                               location.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PROHIBITION ON TRANSPORT OF HYDROLYSATE AT CERTAIN ARMY 
              DEPOTS.

    (a) Prohibition.--The Secretary of Defense may not transport 
hydrolysate from the Pueblo Chemical Depot, Colorado, or the Blue Grass 
Army Depot, Kentucky, to an off-site location for treatment, storage, 
or disposal.
    (b) Savings Clause.--Nothing in this Act limits or otherwise 
affects section 8119 of the Department of Defense Appropriations Act, 
2008 (Public Law 110-116; 50 U.S.C. 1521 note).
                                 <all>
```
NOVO NORDISK PHARMACEUTICAL INDUSTRIES, INC. v. PROGRESS ENERGY, INC.

No. COA05-737.

North Carolina Court of Appeals.

Filed July 18, 2006.

Certification Date August 7, 2006.

Appeal from Johnston (04CVS2298).

Case without published opinion. Dismissed.
<PAGE>

THIS AGREEMENT HAS CONFIDENTIAL PORTIONS OMITTED, WHICH PORTIONS HAVE BEEN FILED
SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. OMITTED PORTIONS ARE
INDICATED IN THIS AGREEMENT WITH "[TEXT OMITTED - CONFIDENTIAL TREATMENT
REQUESTED]."

                                    AMENDMENT


THIS AMENDMENT is entered into by and between American Airlines, Inc. ("AA") and
Sabre Inc. (formerly known as The SABRE Group, Inc.; herein "Sabre") effective
as of March 15, 2000 with respect to the "Marketing Cooperation Agreement"
entered into by and between American and Sabre and dated as of July 1, 1996.
Capitalized terms used herein but not defined have the same meaning given in the
Marketing Cooperation Agreement.

                                   BACKGROUND

1.       The Marketing Cooperation Agreement establishes the terms and
         conditions under which AA would provide different kinds of marketing
         support to Sabre for terms of five or ten years;

2.       Sabre has been operating as an independent company for over three years
         since the Effective Date of the Marketing Cooperation Agreement, and,
         as a result of certain separate transactions expected to occur on or
         about March 15, 2000, Sabre and its parent company, Sabre Holdings
         Corporation, will no longer be affiliates under common control with AA;
         and

3.       In view of the operating history and change in circumstances of Sabre,
         and in consideration of certain changes to certain other agreements
         between AA and Sabre, the parties desire to amend the Marketing
         Cooperation Agreement as set forth in this Amendment.

                                     CLAUSES

NOW THEREFORE, AA and Sabre agree as follows:

[TEXT OMITTED - CONFIDENTIAL TREATMENT REQUESTED]

2.       A new section 5.3.1 is added after section 5.3 (MARKETING AND LICENSING
         AGENT) which will read as follows:

         "5.3.1   AA and Sabre will negotiate in good faith and execute an
                  amendment to the BTS License Agreement concerning the terms
                  and conditions under which AA will be able to use BTS to
                  develop a business travel product for use in conjunction with
                  access to AA's publicly accessible internet site, AA.com."

3.       [TEXT OMITTED - CONFIDENTIAL TREATMENT REQUESTED]



<PAGE>

         IN WITNESS WHEREOF, the parties have caused this AMENDMENT to be
         executed in two or more identical counterparts by their duly authorized
         representatives.

         AMERICAN AIRLINES, INC.                     SABRE INC.

         By:                                         By:
            ---------------------------                 -----------------------
                  Craig S Kreeger

         Title:   Vice President and General         Title:
                     Sales Manager                         --------------------
















                                       -2-
# L_2016297EN.01001201.xml

| 4.11.2016 | EN | Official Journal of the European Union | L 297/12 |
| --- | --- | --- | --- |

4.11.2016

EN

Official Journal of the European Union

L 297/12

---

COMMISSION IMPLEMENTING REGULATION (EU) 2016/1922

of 20 October 2016

entering a name in the register of protected designations of origin and protected geographical indications [Poularde du Périgord (PGI)]

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 1151/2012 of the European Parliament and of the Council of 21 November 2012 on quality schemes for agricultural products and foodstuffs (1), and in particular Article 52(2) thereof,

Whereas:

| (1) | Pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012, France's application to register the name ‘Poularde du Périgord’ was published in the Official Journal of the European Union (2). |
| --- | --- |

(1)

Pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012, France's application to register the name ‘Poularde du Périgord’ was published in the Official Journal of the European Union (2).

| (2) | As no statement of opposition under Article 51 of Regulation (EU) No 1151/2012 has been received by the Commission, the name ‘Poularde du Périgord’ should therefore be entered in the register, |
| --- | --- |

(2)

As no statement of opposition under Article 51 of Regulation (EU) No 1151/2012 has been received by the Commission, the name ‘Poularde du Périgord’ should therefore be entered in the register,

HAS ADOPTED THIS REGULATION:

Article 1

The name ‘Poularde du Périgord’ (PGI) is hereby entered in the register.

The name specified in the first paragraph denotes a product in Class 1.1. Fresh meat (and offal), as listed in Annex XI to Commission Implementing Regulation (EU) No 668/2014 (3).

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 20 October 2016.

For the Commission,

On behalf of the President,

Phil HOGAN

Member of the Commission

---

(1)  
  OJ L 343, 14.12.2012, p. 1.

1

(2)  
  OJ C 228, 24.6.2016, p. 3.

2

(3)  Commission Implementing Regulation (EU) No 668/2014 of 13 June 2014 laying down rules for the application of Regulation (EU) No 1151/2012 of the European Parliament and of the Council on quality schemes for agricultural products and foodstuffs (OJ L 179, 19.6.2014, p. 36).

3

---
STATE v. BROWN.

No. COA05-305.

North Carolina Court of Appeals.

Filed June 6, 2006

Certification Date June 26, 2006

Appeal from Rowan (00CRS50898, 00CRS50899, 00CRS50900)

Case without published opinion. No error.
<PAGE>   1
                                                                      EXHIBIT 23



               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the incorporation by reference in this Annual Report on Form 10-K
of CN Biosciences, Inc., and in the Registration Statements (Form S-8 File Nos.
333-16527 and 333-32891) pertaining to the Company's Amended and Restated 1992
Stock Option Plan of our report dated February 27, 1998, included in the 1997
Annual Report to Stockholders of CN Biosciences, Inc.

Our audits also included the financial statement schedule of CN Biosciences,
Inc. listed in Item 14(a). This schedule is the responsibility of CN
Biosciences, Inc.'s management. Our responsibility is to express an opinion
based on our audits. In our opinion, the financial statement schedule referred
to above, when considered in relation to the basic financial statements taken as
a whole, presents fairly in all material respects the information set forth
therein.


                                        ERNST & YOUNG LLP

San Diego, California
March 10, 1998